Pharmacological preconditioning with GYKI 52466: a prophylactic approach to neuroprotection
Some toxins and drugs can trigger lasting neuroprotective mechanisms that enable neurons to resist a subsequent severe insult. This ‘pharmacological preconditioning’ has far-reaching implications for conditions in which blood flow to the brain is interrupted. We have previously...
Main Authors: | Chelsea S Goulton, Anna R Patten, John R Kerr, Steve Kerr |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2010-08-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnins.2010.00054/full |
Similar Items
-
Src/CK2/PTEN-Mediated GluN2B and CREB Dephosphorylations Regulate the Responsiveness to AMPA Receptor Antagonists in Chronic Epilepsy Rats
by: Ji-Eun Kim, et al.
Published: (2020-12-01) -
PTEN Is Required for The Anti-Epileptic Effects of AMPA Receptor Antagonists in Chronic Epileptic Rats
by: Ji-Eun Kim, et al.
Published: (2020-08-01) -
Preconditioning by ultra-low dose of tramadol reduces the severity of tramadol-induced seizure: Contribution of glutamate receptors
by: Neda Valian, et al.
Published: (2021-01-01) -
Brain Lipopolysaccharide Preconditioning-Induced Gene Reprogramming Mediates a Tolerance State in Electroconvulsive Shock Model of Epilepsy
by: Elham Amini, et al.
Published: (2018-05-01) -
Preconditioning in cardiac anesthesia…… where are we?
by: Ajita Suhrid Annachhatre, et al.
Published: (2019-01-01)